ClinicalTrials.gg
RecruitingNCT06473584PREVADIABRUNUpdated Sep 14, 2026

Study of the Prevalence of Diabetes and Pre-diabetes in Réunion Island

An interventional study of Diabetes detection in Diabetes, sponsored by Centre Hospitalier Universitaire de la Réunion. Recruiting at 1 site in Reunion. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-14.

Sponsored by Centre Hospitalier Universitaire de la Réunion · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
2,000
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

In view of the new priority given to diabetes in Réunion and the implementation of an ambitious plan to combat the disease at regional level, which includes the identification and management of pre-diabetes, the need for up-to-date data on the extent of these 2 diseases (diabetes and pre-diabetes) has become essential.

These two diseases have known risk factors: age, overweight, obesity, high waist circumference, family history, hypertension, eating habits and physical activity, all of which form part of a risk score for developing diabetes: the Findrisk recommended by the Haute Autorité de Santé for identifying people at risk of diabetes. Given the specific population characteristics of Réunion compared with Finland, where this score has been validated, it would seem important to be able to measure these risk indicators in the population as a function of carbohydrate status in order to check that the proposed thresholds are appropriate for the population of Réunion.

Finally, cardiovascular risk has been described as early as the pre-diabetes stage. Given the young age of onset of diabetes in Réunion and the high proportion of diagnoses of diabetes made following the occurrence of a cardiovascular complication, the study of the prognosis of carbohydrate status on the occurrence of complications using the social security information system will be offered on a voluntary basis to study subjects (via a probabilistic social security link).

02

Conditions studied

  • Diabetes

Browse trials for

03

In context

Diabetes Mellitus

8,290 studies on the registry are indexed under Diabetes Mellitus; 1,077 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 80 across 6,023 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Centre Hospitalier Universitaire de la Réunion is the lead sponsor of 141 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have lived in Réunion island for at least one year
  • Be aged between 18 and 75
  • Affiliated to or benefiting from a social security scheme
  • Free, informed and signed consent

Exclusion criteria

Exclusion Criteria:

  • No main residence on the island or fixed address for at least one year on the island
  • Participation in experimental research
  • Pregnant women
  • Adults under guardianship or legal protection
  • Not understanding French
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
2,000 participants (estimated)

Study arms

  • Other
    Detection of glycaemic anomalies

    Diagnostic Test: Diabetes detection

Interventions

  • Diagnostic testDiabetes detection

    Fasting glycemia on blood sample

06

What researchers measure

Primary outcomes

  1. Estimating the prevalence of glycaemic abnormalities (diabetes and pre-diabetes) in Réunion

    Measurement of fasting blood glucose and blood glucose 2 hours after ingesting 75g of glucose (HGPO test) according to Haute Autorite de Sante (HAS) recommendations used in France for diagnosing diabetes and pre-diabetes in people with unknown diabetes

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06473584
Collaborators
Agence Régionale de Santé de La Réunion
Responsible party
Sponsor
First posted
Jun 25, 2024
Start date
Apr 2, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 14, 2026

Study contacts

Catherine MARIMOUTOU, MD, PhD
Contact
catherine.marimoutou@chu-reunion.fr
+262 (0)262 90 50 50
Florence LEFEBVRE D'HELLENCOURT
Contact
florence.lefebvre-dhellencourt@chu-reunion.fr
+262 262 75 34 71
Catherine MARIMOUTOU, MD, PhD
principal investigator · CHU La Réunion

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion